Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current L1CA34 market cap is 26.24B. The company's latest EPS is USD 4.9234 and P/E is 48.49.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.06B | 3.03B | 3.18B | 3.22B | 3.28B |
| Operating Income | 252M | -122.7M | 321.4M | 294.5M | 253.6M |
| Net Income | 183.3M | -167.1M | 228M | 205.3M | 169.3M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.55B | 13.98B | 16.12B | 14.88B | 12.16B |
| Operating Income | 1.34B | 2.45B | 3.29B | 1.78B | 724.2M |
| Net Income | 823.8M | 1.56B | 2.38B | 1.28B | 418M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 16.89B | 16.73B | 16.53B | 16.71B | 18.61B |
| Total Liabilities | 8.99B | 8.83B | 8.56B | 8.69B | 10.43B |
| Total Equity | 7.87B | 7.88B | 7.96B | 8.01B | 8.17B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.05B | 20.07B | 20.39B | 20.16B | 16.73B |
| Total Liabilities | 10.46B | 10.69B | 10.09B | 10.04B | 8.83B |
| Total Equity | 7.57B | 9.36B | 10.27B | 10.1B | 7.88B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 748.1M | 1.33B | -29.8M | 531.3M | 808.6M |
| Investing | -840.9M | -1.17B | -393.1M | -578.1M | -1.16B |
| Financing | 387.2M | -59.3M | -11.7M | -221.7M | 1.33B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.44B | 2.14B | 3.11B | 1.96B | 1.33B |
| Investing | -1.28B | -643.2M | -884.6M | -1.65B | -1.17B |
| Financing | -252.7M | -517.4M | -2.07B | -1.32B | -59.3M |
| Market Cap | 26.24B |
| Price to Earnings Ratio | 48.49 |
| Price to Sales Ratio | 1.67 |
| Price to Cash Ratio | 37.76 |
| Price to Book Ratio | 2.57 |
| Dividend Yield | 1.29% |
| Shares Outstanding | 84.9M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 18.18% |
| 52 Week High | 339.32 |
| 52 Week Low | 250.00 |
| Spread (Intraday) | 20.65 (5.63%) |
| Company Name | Laboratory Corp of America Holdings |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.labcorp.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
